739.1500 11.80 (1.62%)
NSE Sep 25, 2026 15:31 PM
Volume: 287.9K
 

739.15
1.62%
Axis Direct
We expect Gross Margins to be impacted due to an increase in revenue share from non-regulated markets and an increase in raw material prices going onwards. Hence, we recommend a HOLD rating on the stock with a target price of INR 1,670 (PE 20x for FY23EPS).
Solara Active Pharma Sciences Ltd. is trading above all available SMAs
More from Solara Active Pharma Sciences Ltd.
Recommended